5-Amino-1mq Lab Tested

What Does Lab-Tested 5-Amino-1MQ Mean for Research Applications?

Lab-tested 5-Amino-1MQ refers to synthetic 5-amino-1-methylquinolinium that has undergone rigorous analytical validation—including reverse-phase high-performance liquid chromatography (RP-HPLC) for purity and electrospray ionization mass spectrometry (ESI-MS) for structural confirmation—to verify compound identity and sequence integrity prior to in vitro or animal studies.

In preclinical settings, non-validated small molecules often contain synthesis residues, heavy metals, or structural isomers that distort assay outcomes. Establishing chemical purity (>98%) and verifying low endotoxin thresholds through independent ISO 17025 accredited testing laboratories ensures that observed bioactivity in cellular models stems exclusively from targeted NNMT inhibition rather than synthetic contaminants.

Molecular Mechanism: NNMT Inhibition and Cellular Energetics

Nicotinamide N-methyltransferase (NNMT) is a cytosolic enzyme that catalyzes the transfer of a methyl group from S-adenosylmethionine (SAM) to nicotinamide (NAM), producing 1-methylnicotinamide (MNA) and S-adenosylhomocysteine (SAH). In tissue types with elevated NNMT expression, such as white adipose tissue and certain parenchymal cells, this enzymatic activity acts as a sink for both methyl donors and nicotinamide availability.

By binding selectively to the NNMT active site, 5-Amino-1MQ prevents the methylation of nicotinamide. This enzymatic block halts the clearance of NAM, permitting its salvage back into the nicotinamide adenine dinucleotide (NAD+) biosynthesis pathway via nicotinamide phosphoribosyltransferase (NAMPT). Preclinical investigations demonstrate that inhibiting NNMT directly increases intracellular NAD+ pools, thereby altering the NAD+/NADH ratio essential for mitochondrial electron transport chain efficiency.

Furthermore, by conserving SAM availability, NNMT inhibition influences histone methylation state and global epigenetic regulation within metabolic target tissues. Researchers utilize lab-tested 5-Amino-1MQ to map how modulating methyl donor kinetics regulates nuclear gene expression involved in fatty acid oxidation and glycolytic flux.

Preclinical Findings: NAD+ Elevation and Mitochondrial Output

Mitochondrial dysfunction and diminished NAD+ availability are hallmarks of metabolic decline in cellular and animal models. In vitro studies using murine adipocytes and skeletal muscle myotubes show that treatment with 5-Amino-1MQ leads to measurable increases in intracellular NAD+ concentration, enhanced basal oxygen consumption rate (OCR), and elevated reserve respiratory capacity.

In high-fat diet rodent models, administration of selective NNMT inhibitors has demonstrated significant metabolic shifts without altering total caloric intake. Researchers observed increased energy expenditure, upregulated expression of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), and heightened mitochondrial biogenesis markers in skeletal muscle tissue.

These empirical observations suggest that restoring NAD+ homeostasis via NNMT inhibition plays a pivotal role in maintaining mitochondrial membrane potential and adenosine triphosphate (ATP) synthesis rates. Investigating these biochemical cascades requires stable, high-purity reagents available across the broader catalog of research peptides and metabolic probes.

Adipose Tissue Metabolism and Substrate Utilization

White adipose tissue (WAT) serves as a primary site of NNMT over-expression under conditions of metabolic stress. Preclinical studies indicate that elevated NNMT activity in WAT correlates with suppressed rate of beta-oxidation and reduced lipolytic sensitivity. Lab-tested 5-Amino-1MQ is frequently employed in 3T3-L1 adipocyte cell lines to measure changes in intracellular lipid droplet accumulation.

Data from murine models demonstrate that targeted NNMT knockdown or pharmacological inhibition leads to shrinking adipocyte soma size and reduced systemic fat mass accumulation. Researchers analyzing substrate utilization pathways report elevated expressions of carnitine palmitoyltransferase 1 (CPT-1) and uncoupling protein 1 (UCP-1), signaling a phenotypic shift toward active thermogenesis.

By utilizing analytical-grade 5-Amino-1MQ, investigators can precisely quantify changes in adipokine secretion profiles—such as adiponectin and leptin dynamics—under controlled culture conditions. Explore comprehensive protocol guides in our dedicated research library to examine standardized methodology for metabolic enzyme assays.

Analytical Verification Standards: HPLC, Mass Spectrometry, and Endotoxin Testing

Ensuring experimental reproducibility demands strict quality control metrics for every lot of 5-Amino-1MQ. Purity verification begins with reverse-phase high-performance liquid chromatography (RP-HPLC) using ultraviolet (UV) detection. A clear, sharp chromatogram with an integrated peak area exceeding 98% confirms the absence of unreacted precursors or side-reaction degradation products.

Mass spectrometry (ESI-MS) provides definitive molecular weight verification. The resulting m/z spectrum must match the theoretical mass of 5-amino-1-methylquinolinium (exact mass ~159.09 g/mol for the cation) down to fractional mass units, confirming structural identity without molecular rearrangement or fragment misassignment.

In addition to chemical purity, bacterial endotoxin screening via the Limulus Amebocyte Lysate (LAL) assay is critical for cell culture and preclinical animal models. High endotoxin levels trigger non-specific inflammatory signaling pathways through Toll-like receptor 4 (TLR4), confounding metabolic measurements. PX1 Research enforces strict endotoxin limits (<0.01 EU/mg) verified by independent ISO 17025 accredited laboratories for every batch.

Comparative Analysis: 5-Amino-1MQ and Metabolic Research Compounds

In metabolic and mitochondrial research, 5-Amino-1MQ operates through a distinct pathway compared to other signaling peptides and small molecules. While 5-Amino-1MQ acts upstream by blocking NNMT to elevate intracellular NAD+, mitochondrial-derived peptides like MOTS-c act as hormonal signals that directly translocate to the nucleus to regulate folate cycles and AMPK activation during metabolic stress.

Similarly, targeted lipolytic fragments such as AOD-9604 stimulate fat metabolism through beta-3 adrenergic and growth hormone receptor pathway modulation without influencing the NAD+ salvage pathway or methyl-donor clearance. Synthetic agonist compounds like SLU-PP-332 target estrogen-related receptors (ERRs) to promote oxidative muscle fiber conversion.

Evaluating these compounds side-by-side allows laboratory researchers to dissect complementary regulatory nodes: 5-Amino-1MQ addresses enzymatic NAD+ depletion, MOTS-c regulates metabolic gene transcription, AOD-9604 targets lipid mobilize signaling, and ERR agonists drive oxidative capacity. Sourcing these compounds through a verified wholesale account guarantees batch uniformity across multi-arm comparative studies.

Laboratory Reconstitution, Solubility, and Handling Guidelines

5-Amino-1MQ is typically supplied as a lyophilized salt (e.g., iodide or chloride salt). Proper reconstitutions require strict adherence to solvent polarity and solubility thresholds. The compound exhibits optimal solubility in dimethyl sulfoxide (DMSO) at concentrations exceeding 20 mg/mL, as well as moderate solubility in sterile physiological saline or phosphate-buffered saline (PBS) depending on the counterion.

For cell culture assays, preparing stock solutions in high-purity DMSO followed by dilution into aqueous culture media is standard practice. Care must be taken to maintain the final organic solvent concentration below 0.1% v/v to prevent solvent-induced cytotoxicity or alterations in cellular membrane permeability.

Lyophilized powder should be stored at -20°C in a desiccated container protected from light. Reconstituted liquid stock solutions ought to be aliquoted into single-use microcentrifuge tubes to avoid repeated freeze-thaw cycles, which can cause chemical degradation over time.

Quality Assurance and Sourcing from PX1 Research

PX1 Research enforces rigorous quality assurance standards for all research compounds. Every lot of 5-Amino-1MQ is synthesized under strict quality control protocols in state-of-the-art facilities and undergoes exhaustive verification before release.

Our analytical testing process includes lot-specific Certificates of Analysis (COAs) detailing RP-HPLC purity profiles, ESI-MS mass confirmation, residual solvent screening, and LAL endotoxin quantification. Researchers gain transparent access to raw analytical data, ensuring full traceabilty from synthesis to laboratory bench.

All orders ship directly from centralized fulfillment centers located in California and Arizona, featuring same-day dispatch for orders placed Monday through Friday before cut-off times. This streamlined infrastructure minimizes transit times and preserves reagent integrity for sensitive assay requirements.

Future Directions in NNMT Inhibitor Preclinical Research

Research surrounding NNMT inhibitors extends beyond primary adipocyte kinetics. Current preclinical studies explore the role of 5-Amino-1MQ in sarcopenia and skeletal muscle regeneration. In aging mouse models, NNMT activity rises in muscle stem cells (satellite cells), impairing their regenerative capacity; targeted inhibition has been shown to restore proliferation rates and muscle fiber repair post-injury.

Additional frontiers involve investigating NNMT expression in oncology and metabolic liver disorders, such as non-alcoholic fatty liver disease (NAFLD). By standardizing small-molecule quality and utilizing lab-tested reagents, academic and private research institutions can isolate biochemical mechanisms with uncompromised analytical precision.